CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – India

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

GlobalData, the industry analysis specialist, has released its latest report: CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – India. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in India. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts. India is the second most populated country in the world with a population of approximately 1.24 billion in 2014. The country’s pharmaceutical market was estimated at $24.2 billion in 2014 and is expected to reach approximately $60.5 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 16.5%. The value of the Indian medical device market was $6.6 billion in 2008, and is expected to register a CAGR of 7.7% to reach an estimated $10.3 billion in 2020. The main growth factors are: Increasing coverage of healthcare insurance Improving access to medical facilities in both urban and rural areas Government initiatives for easy access to healthcare facilities

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in India, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market: Dr Reddy’s, Lupin, Cipla, Aurobindo and Cadila; and profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, Johnson & Johnson, DePuy, Roche and Philips

Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving India’s healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect India’s healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships

Identify, understand, and capitalize on the opportunities and challenges in India’s healthcare market

Table of Contents

Table of Contents

1Table of Contents

1.1List of Tables

1.2List of Figures

2Introduction

2.1GlobalData Report Guidance

3Overview of the Pharmaceutical and Medical Device Markets

3.1Pharmaceutical Market

3.1.1Market Overview

3.1.2Pharmaceutical Exports and Imports

3.1.3Supply Channels

3.1.4Market Segments

3.1.5Major Therapeutic Areas

3.1.6Major Players

3.2Medical Device Market

3.2.1Market Overview

3.2.2Overview of Top Five Segments

3.2.3Diagnostic market

3.2.4Major Players

3.3Market Drivers and Barriers

3.3.1Drivers

3.3.2Barriers

4Market Access

4.1Reimbursement and Payer Landscape

4.1.1Overview of Healthcare System

4.1.2Reimbursement Process

4.1.3Overview of Insurance Providers

4.1.4Patient Share in Healthcare Spending

4.1.5Drug Price Change

4.1.6Pricing Policies

4.2Regulatory Landscape

4.2.1Overview of Regulatory Agencies

4.2.2New Drug Approval Procedure for Pharmaceutical Products

4.2.3Market Authorization Procedure for Medical Devices

4.2.4Licensing Process for Pharmaceutical and Medical Device Manufacturing

4.2.5Licensing Process for Pharmaceutical Exports and Imports

4.2.6Intellectual Property Rights

4.2.7Clinical Trial Regulations

4.2.8Pharmaceutical Advertising Regulations

4.2.9Pharmacy Regulations

4.2.10Labeling and Packaging Regulations

5Country Analysis

5.1Political Environment

5.1.1Political Structure

5.1.2Analysis of the Current Political Environment

5.1.3Healthcare Policy Initiatives

5.2Economic Landscape

5.3Economic Indicators

5.3.1Gross Domestic Product

5.3.2National Income per Capita

5.3.3Inflation

5.3.4Currency Exchange Rate

5.3.5Foreign Direct Investment

5.3.6Foreign Exchange Reserves

5.3.7Trade Balance

5.3.8Government Structural Balance

5.3.9General Government Gross Debt

5.3.10Major Industries

5.4Demographics

5.4.1Population

5.4.2Education and Literacy

5.4.3Employment

5.4.4Disease Burden

5.5Healthcare Infrastructure

5.5.1Healthcare Facilities

5.5.2Healthcare Parameters

5.5.3Environmental Health

5.5.4Healthcare Personnel

5.6Healthcare Expenditure

5.6.1Overview

5.6.2Components of Healthcare Spending

5.6.3Public and Private Sector Share

5.6.4Spending in Pharmaceutical R&D

5.7Trade Associations

5.7.1Indian Pharmaceutical Association

5.7.2Indian Drug Manufacturer’s Association

5.7.3Organization of Pharmaceutical Producers of India

5.7.4Indian Pharmacy Graduates Association

5.8Trade Fairs

6Opportunities and Challenges

6.1Opportunities

6.2Challenges

7Appendix

7.1Abbreviations

7.2Bibliography

7.3Research Methodology

7.3.1Coverage

7.3.2Secondary Research

7.3.3Forecasts

7.3.4Expert Panel

7.4Disclaimer

Table

Table 1: Pharmaceutical Market, India, Revenue ($bn), 2008–2014

Table 2: Pharmaceutical Market, India, Revenue Forecast ($bn), 2014–2020

Table 3: Pharmaceutical Market, India, Exports and Imports ($bn), 2008–2013

Table 4: Biotechnology Market, India, Market Segments of Bio-technology Industry, Share (%), 2015

Table 5: Major Therapeutic Areas, India, Turnover ($m), 2010

Table 6: Dr. Reddy’s, Global, Major Products, 2014

Table 7: Dr Reddy’s, Global, Late-Stage Pipeline, 2015

Table 8: Medical Device Market, India, Revenue ($bn), 2008–2014

Table 9: Medical Device Market, India, Revenue Forecast ($bn), 2015–2020

Table 10: Medical Device Market, India, Revenue by Segment, 2014

Table 11: Medical Device Market, India, Ophthalmic Devices Market ($m), 2008–2014

Table 12: Medical Device Market, India, Ophthalmic Devices Market, Market Share for Major Players (%), 2012

Table 13: Medical Device Market, India, IVD Market ($bn), 2008–2014

Table 14: Medical Device Market, India, IVD Market, Market Share for Major Players (%), 2012

Table 15: Medical Device Market, India, Orthopedic Device Market ($bn), 2008–2014

Table 16: Medical Device Market, India, Orthopedic Device Market, Market Share for Major Players (%), 2012

Table 17: Medical device market, India, Wound Care Management Market ($bn), 2008–2014

Table 18: Medical Device Market, India, Wound Care Management Market, Market Share for Major Players (%), 2012

Table 19: Medical Device Market, India, Cardiovascular Device Market ($bn), 2008–2014

Table 20: Medical Device Market, India, Cardiovascular Device Market, Market Share for Major Players (%), 2012

Table 21: Medical Device Market, India, Diagnostic Market, Revenue ($bn), 2008–2014

Table 22: Medical Device Market, India, Diagnostic Market, Revenue ($bn), 2014–2020

Table 23: Major Public Insurance Schemes, India, 2013

Table 24: Insured Population, India, Share ($bn), 2014

Table 25: Healthcare Spending, India, Out-of-Pocket Expenditure (% of Private Expenditure on Health), 2008–2013

Table 26: Market Access, India, Drug Price Change (%), 2008–2014

Table 27: Specific Requirements, New Drug Application, India, 2015

Table 28: Market Access, India, Schedule of Patent Fees, 2014

Table 29: Market Access, India, Schedule of Trademark Fees, 2014

Table 30: Specific Requirements, Clinical Trial Approval, India, 2011

Table 31: Economic Indicators, India, GDP per Capita ($), 2008–2014

Table 32: Economic Indicators, India, GDP per Capita Forecast ($), 2015–2020

Table 33: Economic Indicators, India, GDP Annual Growth (%), 2008–2014

Table 34: Economic Indicators, India, GDP Annual Growth Forecast (%), 2015–2020

Table 35: Economic Indicators, India, National Income per Capita ($), 2008–2014

Table 36: Economic Indicators, India, Average Consumer Price Index Forecast, 2008–2014

Table 37: Economic Indicators, India, Average Consumer Price Index Forecast, 2015–2020

Table 38: Economic Indicators, India, Average Consumer Price Annual Change (%), 2008–2014

Table 39: Economic Indicators, India, Currency Exchange Rate (INR/$), 2008–2014

Table 40: Economic Indicators, India, FDI ($bn), 2008–2014

Table 41: Economic Indicators, India, Foreign Exchange Reserves ($bn), 2008–2014

Table 42: Economic Indicators, India, Imports of Goods and Services ($bn), 2008–2014

Table 43: Economic Indicators, India, Exports of Goods and Services ($bn), 2008–2014

Table 44: Economic Indicators, India, Government Structural Balance ($bn), 2008–2014

Table 45: Economic Indicators, India, General Government Gross Debt (% of GDP), 2008–2014

Table 46: Economic Indicators, India, General Government Gross Debt Forecast (% of GDP), 2015–2020

Table 47: Economic Indicators, India, Major Industries, National income by Industry ($bn), 2013

Table 48: Demographics, India, Population (billion), 2008–2014

Table 49: Demographics, India, Population Forecast (billion), 2015–2020

Table 50: Demographics, India, Urban-Rural Population (%), 2008–2014

Table 51: Demographics, India, Population Distribution by Age Group (%), 2008–2014

Table 52: Demographics, India, Population Distribution by Age Group Forecast (%), 2015–2020

Table 53: Demographics, India, Births (per 1,000 Population), 2008–2014

Table 54: Demographics, India, Mortality (per 1,000 Population), 2008–2014

Table 55: Demographics, India, Major Causes of Mortality (%), 2012

Table 56: Demographics, India, Children <5 Years Age, Infant Mortality Rate (per 1,000 Live Births), 2008–2014

Table 57: Demographics, India, Immunization Rate (%), 2013

Table 58: Demographics, India, Major Causes of Male Mortality (‘000), 2008

Table 59: Demographics, India, Major Causes of Male Mortality (‘000), 2008

Table 60: Demographics, India, Gender Ratio (M/F), 2008–2014

Table 61: Demographics, India, Life Expectancy at Birth (Years), 2008–2014

Table 62: Demographics, India, Number of students enrolled by level of education (millions), 2013

Table 63: Demographics, India, Unemployment Rate (%), 2008–2014

Table 64: Demographics, India, Employment by Sector (Number of Employees, Millions), 2013

Table 65: Demographics, India, Disease burden, DALYs, 2013

Table 66: Healthcare Infrastructure, India, Public Hospitals, 2008–2014

Table 67: Major Private Hospitals, India, 2012

Table 68: Healthcare Infrastructure, India, Urban-rural share (%), 2008–2014

Table 69: Healthcare Infrastructure, India, Healthcare Centers, 2008–2014

Table 70: Healthcare Infrastructure, Diagnostic Units (Per 100,000 Population), 2008

Table 71: Healthcare Infrastructure, India, Hospital Beds (per 1,000 Population), 2008–2014

Table 72: Healthcare Infrastructure, India, Doctors (‘000), 2008–2014

Table 73: Healthcare Infrastructure, India, PM10 (µg/m3), 2008–2014

Table 74: Healthcare Infrastructure, India, CO2 emissions (mt per Capita), 2008–2014

Table 75: Healthcare Infrastructure, India, Nurses (per 1,000 Population), 2008–2014

Table 76: Healthcare Infrastructure, India, Pharmacists (per 1,000 Population), 2008–2014

Table 77: Healthcare Infrastructure, India, Dentists (per 1,000 Population), 2008–2014

Table 78: Healthcare Expenditure, India , Healthcare Expenditure (% of GDP), 2008–2014

Table 79: Healthcare Expenditure of Ministry of Health and Family Welfare, India, Share by Department (%), 2014

Table 80: Healthcare Expenditure, India, Major Components of Healthcare Spending, Share (%), 2013

Table 81: Healthcare Expenditure, India, Public-Private Share (%), 2008–2014

Table 82: Healthcare Expenditure, India, Pharmaceutical R&D Expenditure ($m), 2008–2014

Table 83: Healthcare Expenditure, India Major Healthcare Trade Fairs, 2015–2016

Figures

Figure 1: Pharmaceutical Market, India, Revenue ($bn), 2008–2014

Figure 2: Pharmaceutical Market, India, Revenue Forecast ($bn), 2015–2020

Figure 3: Pharmaceutical Market, India, Exports and Imports ($bn), 2008–2014

Figure 4: Pharmaceutical Market, India, Supply Channels, 2013

Figure 5: Biotechnology Market, India, Market Segments of Bio-technology Industry, Share (%), 2015

Figure 6: Major Therapeutic Areas, India, Turnover ($m), 2010

Figure 7: Medical Device Market, India, Revenue ($bn), 2008–2014

Figure 8: Medical Device Market, India, Revenue Forecast ($bn), 2015–2020

Figure 9: Medical Device Market, India, Revenue by Segment ($bn), 2014

Figure 10: Medical Device Market, India, Ophthalmic Devices Market ($m), 2008–2014

Figure 11: Medical Device Market, India, Ophthalmic Devices Market, Market Share for Major Players (%), 2012

Figure 12: Medical Device Market, India, IVD Market ($m), 2008–2014

Figure 13: Medical Device Market, India, IVD Market, Market Share for Major Players (%), 2012

Figure 14: Medical Device Market, India, Orthopedic Device Market ($bn), 2008–2014

Figure 15: Medical Device Market, India, Orthopedic Device Market, Market Share for Major Players (%), 2012

Figure 16: Medical Device Market, India, Wound Care Management Market ($bn), 2008–2014

Figure 17: Medical device market, India, Wound Care Management Market ($m), Market share for Major Players (%), 2012

Figure 18: Medical Device Market, India, Cardiovascular Device Market ($bn), 2008–2014

Figure 19: Medical Device Market, India, Cardiovascular Device Market, Market Share for Major Players (%), 2012

Figure 20: Medical Device Market, India, Diagnostic Market, Revenue ($bn), 2008–2014

Figure 21: Medical Device Market, India, Diagnostic Market, Revenue ($bn), 2015–2020

Figure 22: Healthcare Market, India, Drivers and Barriers, 2015

Figure 23: Milestones of the Insurance Regulatory System, India, 1938–2009

Figure 24: Healthcare System, India, Medical Tourism Process, 2008

Figure 25: Local Purchase System, Private Hospitals, India, 2013

Figure 26: Centralized Purchase System, Private Hospitals, India, 2013

Figure 27: Tender Purchase System, Private Hospitals, India, 2013

Figure 28: Local and Centralized Purchase System, Private Hospitals, India, 2013

Figure 29: Healthcare Spending, India, Out-of-Pocket Expenditure (% of Private Expenditure on Health), 2008–2014

Figure 30: Market Access, India, Drug Price Change (%), 2008–2014

Figure 31: Market Access, India, Structure of the Central Drugs Standard Control Organization, 2015

Figure 32: Market Access, India, New Drug Evaluation Process, 2014

Figure 33: Organizational Structure of the Controller General of Patents, Designs and Trade Marks, India, 2015

Figure 34: Patent Approval Process, India, 2015

Figure 35: Trademark Registration Process, India, 2015

Figure 36: Clinical Trial Approval Process, India, 2013

Figure 37: Economic Indicators, India, GDP per Capita ($), 2008–2014

Figure 38: Economic Indicators, India, GDP per Capita Forecast ($), 2015–2020

Figure 39: Economic Indicators, India, GDP Annual Growth (%), 2008–2014

Figure 40: Economic Indicators, India, GDP Annual Growth Forecast (%), 2015–2020

Figure 41: Economic Indicators, India, National Income per Capita ($),2008–2014

Figure 42: Economic Indicators, India, Average Consumer Price Index, 2008–2014

Figure 43: Economic Indicators, India, Average Consumer Price Index, 2015–2020

Figure 44: Economic Indicators, India, Average Consumer Price Annual Change (%), 2008–2014

Figure 45: Economic Indicators, India, Currency Exchange Rate (INR/$), 2008–2014

Figure 46: Economic Indicators, India, FDI ($bn), 2008–2014

Figure 47: Economic Indicators, India, Foreign Exchange Reserves ($bn), 2008–2014

Figure 48: Economic Indicators, India, Imports of Goods and Services ($bn), 2008–2014

Figure 49: Economic Indicators, India, Exports of Goods and Services ($bn), 2008–2014

Figure 50: Economic Indicators, India, Government Structural Balance ($bn), 2008–2014

Figure 51: Economic Indicators, India, General Government Gross Debt (% of GDP), 2008–2014

Figure 52: Economic Indicators, India, General Government Gross Debt Forecast (% of GDP), 2015–2020

Figure 53: Economic Indicators, India, Major Industries, National Income by Industry ($bn), 2013

Figure 54: Demographics, India, Population (billion), 2008–2014

Figure 55: Demographics, India, Population Forecast (billion), 2015–2020

Figure 56: Demographics, India, Urban-Rural Population (%), 2008–2014

Figure 57: Demographics, India, Population Distribution by Age Group (%), 2008–2014

Figure 58: Demographics, India, Population Distribution by Age Group Forecast (%), 2015–2020

Figure 59: Demographics, India, Births (per 1,000 Population), 2008–2014

Figure 60: Demographics, India, Mortality (per 1,000 Population), 2008–2014

Figure 61: Demographics, India, Major Causes of Mortality (%), 2012

Figure 62: Demographics, India, Infant Mortality Rate (per 1,000 Live Births), 2008–2014

Figure 63: Demographics, India, Immunization Rate (%), 2013

Figure 64: Demographics, India, Major Causes of Male Mortality (‘000), 2008

Figure 65: Demographics, India, Major Causes of Female Mortality (‘000), 2008

Figure 66: Demographics, India, Gender Ratio (M/F), 2008–2014

Figure 67: Demographics, India, Life Expectancy at Birth (Years), 2008–2014

Figure 68: Demographics, India, Number of Students Enrolled by Level of Education (millions), 2013

Figure 69: Demographics, India, Unemployment Rate (%), 2008–2014

Figure 70: Demographics, India, Employment by Sector (Number of Employees, Millions), 2013

Figure 71: Demographics, India, Disease burden, DALYs (per 100,000 Population), 2013

Figure 72: Healthcare Infrastructure, India, Public Hospitals, 2008–2014

Figure 73: Healthcare Infrastructure, India, Urban rural share (%), 2008–2014

Figure 74: Healthcare Infrastructure, India, Healthcare centers, 2008–2014

Figure 75: Healthcare Infrastructure, India, Diagnostic Equipment (per 100,000 population), 2008

Figure 76: Healthcare Infrastructure, India, Hospital Beds (per 1,000 Population), 2008–2014

Figure 77: Healthcare Infrastructure, India, Doctors (‘000), 2008–2014

Figure 78: Healthcare Infrastructure, India, PM10 (µg/m3), 2008–2014

Figure 79: Healthcare Infrastructure, India, CO2 emissions (mt per capita), 2008–2014

Figure 80: Healthcare Infrastructure, India, Nurses (per 1,000 Population), 2008–2014

Figure 81: Healthcare Infrastructure, India, Pharmacists (per 1,000 Population), 2008–2014

Figure 82: Healthcare Infrastructure, Dentists (per 1,000 Population), 2008–2014

Figure 83: Healthcare Expenditure, India, Healthcare Expenditure (% of GDP), 2008–2014

Figure 84: Healthcare Expenditure of Ministry of Health and Family Welfare, India, Share by Department (%), 2014

Figure 85: Healthcare Expenditure, India, Major Components of Healthcare Spending, Share (%), 2013

Figure 86: Healthcare Expenditure, India, Public-Private Share (%), 2008–2014

Figure 87: Healthcare Expenditure, India, Pharmaceutical R&D Expenditure ($m), 2008–2014

Figure 88: Healthcare Market, India, Opportunities and Challenges, 2015

Frequently asked questions

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – India thematic reports
Currency USD
$1,995

Can be used by individual purchaser only

$5,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – India was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – India in real time.

  • Access a live CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – India dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.